Melphalan
Drug Details
- Generic Name
- Melphalan
- Brand Names
- EVOMELA
- Application Number
- NDA207155
- Sponsor
- DARMERICA, LLC
- NDC Codes
- 4
- Dosage Forms
- POWDER, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- MELPHALAN, MELPHALAN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Evomela is an alkylating drug indicated for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma. ( 1.1 ) 1.1 Multiple Myeloma-Conditioning Treatment Evomela is indicated for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma.